title: Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide.
authors.forename: C A
authors.initials: CA
authors.lastname: Hoefnagel
authors.forename: E M
authors.initials: EM
authors.lastname: Rankin
authors.forename: R A
authors.initials: RA
authors.lastname: Valdés Olmos
authors.forename: S P
authors.initials: SP
authors.lastname: Israëls
authors.forename: S
authors.initials: S
authors.lastname: Pavel
authors.forename: A G
authors.initials: AG
authors.lastname: Janssen
mesh_terms: D000328:Adult; D001549:Benzamides; D003287:Contrast Media; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000556:secondary; D011759:Pyrrolidines; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D013004:Somatostatin / Q000031:analogs & derivatives*
chemical_list: D001549:Benzamides; D003287:Contrast Media; D065127:Dopamine D2 Receptor Antagonists; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D013004:Somatostatin; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; C081788:pentetreotide